---
figid: PMC7072933__ijms-21-01266-g001
figtitle: Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Hepatitis B virus
- Streptomyces hygroscopicus
pmcid: PMC7072933
filename: ijms-21-01266-g001.jpg
figlink: pmc/articles/PMC7072933/figure/ijms-21-01266-f001/
number: F1
caption: (A) A simple scheme of the mammalian target of rapamycin (mTOR) signaling
  pathway showing action sites for rapalogs and currently available compounds for
  patients with chronic liver disease, like sorafenib or ursodeoxycholic acid (UDCA),
  which have been shown to prevent liver damage by interfering with the mTOR pathway.
  (B) Common causes of cirrhosis and HCC such as alcoholic liver disease, chronic
  viral hepatitis (B,C), non-alcoholic steatohepatitis and cholestatic liver diseases
  exert liver damage by causing an abnormal regulation of the mTOR signaling pathway
  in hepatocytes, which in turn regulates cellular lipid metabolism, autophagy and
  lysosome biogenesis or cellular growth and proliferation. Green, indicates mTOR
  pathway activation; Red, indicates mTOR pathway repression; arrowhead, activation;
  roundhead, inhibition.
papertitle: Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma.
reftext: Gustavo Ferr√≠n, et al. Int J Mol Sci. 2020 Feb;21(4):1266.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8461399
figid_alias: PMC7072933__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7072933__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7072933__ijms-21-01266-g001.html
  '@type': Dataset
  description: (A) A simple scheme of the mammalian target of rapamycin (mTOR) signaling
    pathway showing action sites for rapalogs and currently available compounds for
    patients with chronic liver disease, like sorafenib or ursodeoxycholic acid (UDCA),
    which have been shown to prevent liver damage by interfering with the mTOR pathway.
    (B) Common causes of cirrhosis and HCC such as alcoholic liver disease, chronic
    viral hepatitis (B,C), non-alcoholic steatohepatitis and cholestatic liver diseases
    exert liver damage by causing an abnormal regulation of the mTOR signaling pathway
    in hepatocytes, which in turn regulates cellular lipid metabolism, autophagy and
    lysosome biogenesis or cellular growth and proliferation. Green, indicates mTOR
    pathway activation; Red, indicates mTOR pathway repression; arrowhead, activation;
    roundhead, inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd36
  - Cpe
  - Mtor
  - pk
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Tsc2
  - Tsc1
  - Mdk
  - Rheb
  - Ephb2
  - Mapk1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - CD36
  - FAT1
  - MTOR
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - KRAS
  - HRAS
  - NRAS
  - MAPKAP1
  - RICTOR
  - MLST8
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC2
  - TSC1
  - CCL26
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - RHEB
  - RHEBP1
  - EPHB2
  - MAPK1
  - MAPK3
  - RPTOR
  - HCC
  - HYCC1
  - Sorafenib
  - alcohol
  - Amino
  - Steatosis
  - Liver Injury Inflammation
---
